E

Exelixis

Biopharmaceutical oncology company developing cancer therapies

Associate Regulatory Affairs Strategy Director - Oncology

Regulatory & Quality (Life Sciences)Updated on Nov 10
Full-timeAlameda, CA, USA

About the Job

Requirements

  • A Bachelor's degree in a related discipline and at least eleven years of related experience; or a Master's degree in a related discipline and at least nine years of related experience; or a PhD degree in a related discipline and at least five years of related experience; or an equivalent combination of education and experience.
  • Ability to develop and manage plans within established timelines, balance commitments across multiple activities, and deliver high-quality work.
  • Wide knowledge of the regulatory framework and industry practices to develop innovative approaches and complete complex work.
  • Clear and effective verbal and written communication, including providing timely and appropriate information updates and presenting effectively to departmental colleagues.
  • Interpersonal skills to accommodate differing views and actively support agreed-upon resolutions.
  • Ability to engage internal stakeholders and manage performing teams to achieve common objectives and productive collaborative relationships.
  • Knowledge of organizational goals and objectives, and skill in gathering, analyzing, and applying information to solve problems.
  • Ability to lead self and others with integrity and build trust with colleagues.
  • Ability to manage multiple tasks, prioritize and execute work, anticipate and resolve task-related challenges, and design solutions that consider broader impacts.

Responsibilities

  • Interact directly with regulatory authorities.
  • Conduct timely regulatory intelligence and research to guide study and asset teams, and provide risk assessments and recommendations for regulatory scenarios, including possible expedited pathways.
  • Represent Regulatory Affairs on multidisciplinary teams to establish development and regulatory strategies for early- and late-stage development programs.
  • Work with external vendors to plan, review, prepare, submit, and maintain clinical trial applications (CTAs) in Europe, Asia, and other regions.
  • Review clinical trial documentation, including protocols, informed consents, and clinical study reports, for compliance with regulatory guidance and alignment with study objectives and regulatory strategy.
  • Coordinate, author, and evaluate documents submitted to regulatory health authorities to ensure completeness, organization, quality, appropriate messaging, and compliance with regional regulations.
  • Oversee preparation and completion of electronic and paper regulatory submissions, including investigational new drug applications, supplements and amendments, IND safety reports, annual reports and development safety update reports (DSURs), other routine amendments, and new drug applications (NDA) and biologics license applications (BLA).
  • Contribute to implementing processes and procedures, including developing and authoring internal work instructions and company standard operating procedures (SOPs).
  • Lead multiple assets and/or studies as assigned.
  • Liaise internally with members of Exelixis' functional departments.
  • Liaise externally with vendors, licensors, consultants, and joint development collaborators.
  • Travel approximately 10%.

About the Company

Exelixis

Biopharmaceutical oncology company developing cancer therapies

Exelixis develops and commercializes medicines for cancer. Its products aim to treat advanced cancers, including renal cell carcinoma, by targeting multiple biological pathways and supporting combination regimens to achieve effective, tolerable, and durable responses. The company generates revenue from sales of approved therapies and strategic partnerships, backed by extensive research, clinical trials, and regulatory approvals to bring new drugs to market. Compared with peers, Exelixis focuses on a pipeline that combines multi-pathway targeting with combination therapies to improve patient outcomes. Its overall goal is to advance cancer treatment and offer patients better chances of remission through its ongoing drug development programs.

Company size
1,001-5,000
Company stage
IPO
Headquarters
San Francisco, CA
Founded
1994

Recently Posted Jobs

Explore more opportunities at Exelixis

See more jobs